1	Sunitinib	sunitinib	NC00SC0	C1176020	producto#sustancia	0-9	319_ANS_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
2	.	.	Fp	-	-	9-10	319_ANS_clinical_caseMIR	SENT1	-	-

1	Cetuximab	cetuximab	NC00SC0	C0995188	sustancia#producto	0-9	319_ANS_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
2	.	.	Fp	-	-	9-10	319_ANS_clinical_caseMIR	SENT2	-	-

1	Fluoropirimidina	fluoropirimidina	AQ0FS00	-	-	0-16	319_ANS_clinical_caseMIR	SENT3	B-Grp_Medicamento	-
2	.	.	Fp	-	-	16-17	319_ANS_clinical_caseMIR	SENT3	-	-

1	Panitumumab	panitumumab	NC00SC0	C0879427	sustancia#producto	0-11	319_ANS_clinical_caseMIR	SENT4	B-Grp_Medicamento	-
2	.	.	Fp	-	-	11-12	319_ANS_clinical_caseMIR	SENT4	-	-

1	Bleomicina	bleomicina	NC00SC0	C0005740	producto#sustancia	0-10	319_ANS_clinical_caseMIR	SENT5	B-Grp_Medicamento	-
2	.	.	Fp	-	-	10-11	319_ANS_clinical_caseMIR	SENT5	-	-

